Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.20
-0.05 (-0.69%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $165.04 million as of October 24, 2025. Its market cap has increased by 21.58% in one year.
Market Cap
165.04M
Enterprise Value
158.55M
1-Year Change
21.58%
Ranking
Category
Stock Price
$7.20
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $165.04M, an increase of 8.49%. That is a compound annual growth rate of 7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 166.18M | 6.89% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |